Streetbeat News

Revenues

GOSS

Gossamer Bio, Inc. will present updated seralutinib TORREY open-label extension data for treating PAH and PH-ILD at the American Thoracic Society 2024 International Conference in San Diego, California, from May 17-22.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:15 pm

BOOT

Boot Barn forecasts Q1 earnings per share (EPS) to be between $0.94 and $1.00, below the estimated $1.09. The company anticipates total sales to range from $399M to $407M, slightly above the $398.23M estimate.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:13 pm

NXT

Nextracker forecasts FY25 EPS of $2.89-$3.09, below the $3.15 estimate, with revenue projections of $2.8B-$2.9B, slightly under the $2.89B estimate. The guidance includes details on GAAP net income, EPS, adjusted EBITDA, and adjustments for stock-based compensation and amortization.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:13 pm

RUM

Rumble anticipates a sequential revenue increase starting in Q2 of 2024, driven by new revenue engines and a reduction in guaranteed creator commitments. The company aims for a breakeven point in 2025.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:12 pm

SSTI

SoundThinking (SSTI) has reaffirmed its FY24 revenue guidance to be in the range of $104.0M-$106.0M, aligning closely with the market estimate of $104.842M.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:12 pm

GOEV

Canoo reported its Q1 2024 revenue as $0, which is in line with its revenue from the same period in the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:09 pm

BLIN

Bridgeline Digital reported Q2 2024 adjusted EPS of $(0.02), beating the $(0.03) estimate, but missed sales estimates with $3.80M against the expected $4.22M. This represents a 7.08% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:08 pm

BCDA

BioCardia (NASDAQ:BCDA) reported a Q1 EPS of $(0.09), improving from $(0.17) YoY, but saw a decrease in sales to $55.00K from $64.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:07 pm

ORGN

Origin Mat (ORGN) reported Q1 2024 GAAP EPS of $(0.10), meeting analyst consensus estimates, with sales of $6.82M surpassing the $6.48M estimate. This represents a 300.35% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:03 pm

CNFR

Conifer Holdings (NASDAQ:CNFR) reported Q1 earnings of $0.02 per share, surpassing the $(0.02) estimate, but its sales of $16.89M fell short of the $17.39M estimate. This represents a 33.33% decrease in earnings and a 23.07% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:03 pm